| Trial ID: | L3127 |
| Source ID: | NCT01762657
|
| Associated Drug: |
Oral Cyclosporine And Oral Lansoprazole
|
| Title: |
The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 Diabetes
|
| Acronym: |
IIT
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 1 Diabetes
|
| Interventions: |
DRUG: Oral Cyclosporine and Oral Lansoprazole|DRUG: Placebos
|
| Outcome Measures: |
Primary: Insulin Requirements Among Patients Treated with Oral Cyclosporine and Oral Lansoprazole, 26 and 52 weeks | Secondary: Glucagon C-peptide (under the curve) and Hemoglobin A1C levels among patients with existing type 1 diabetes treated with Cyclosporine and Lansoprazole, 26 and 52 weeks
|
| Sponsor/Collaborators: |
Sponsor: Perle Bioscience, Inc.
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2014-09
|
| Completion Date: |
2015-09
|
| Results First Posted: |
|
| Last Update Posted: |
2016-04-19
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT01762657
|
